Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Genes, Fibrinolysis and Endothelial Dysfunction- Dialysis Aim 3

NCT00878969 is registered in ClinicalTrials.gov with Vanderbilt University as lead sponsor.

NCT NCT00878969
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00878969 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Genes, Fibrinolysis and Endothelial Dysfunction- Dialysis Aim 3
Lead sponsor
Vanderbilt University
Phase
Phase 3
Overall status
Terminated
Start date
January 31, 2010
Completion date
June 30, 2015
Enrollment
78 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

endothelial dysfunction, oxidative stress